Collegium Pharmaceutical Inc

NASDAQ:COLL

30.35

-0.16 (-0.52%)

4:20:00 PM EDT: $30.35 0.00 (0.00%)

Market Cap (Intraday)	970.44M
Current PE	22.11
Forward PE	4.4
2yr Forward PE	4.32

See more stats

Estimates Current Quarter

Revenue	$182.74 Million
Adjusted EPS	$1.66

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

Collegium Pharmaceutical Inc Stock, NASDAQ:COLL

100 Technology Center Drive, Suite 300, Stoughton, Massachusetts 02072

United States of America

Phone: +1.781.713.3699

Number of Employees: 357

http://www.collegiumpharma.com

Description

Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. Its products include Xtampza ER, Nucynta ER and Nucynta IR, Belbuca, and Symproic. The company was founded by Michael Thomas Heffernan in April 2002 and is headquartered in Stoughton, MA.